| SOSTANZE D'ABUSO |
| |
|
DISTURBO DA USO DI SOSTANZE E COMORBILITà PSICHIATRICA PARTE 4
|
|
Barnett PG, Rodgers JH, Bloch DA. A meta-analysis comparing buprenorphine to
methadone for treatment of opiate dependence. Addiction 2001 May;96(5):683-90
Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2
receptor gene variants: association and linkage studies in
impulsive-addictive-compulsive behaviour. Pharmacogenetics 1995 Jun;5(3):121-41
Boyarsky BK, McCance-Katz EF. Improving the quality of substance dependency
treatment with pharmacotherapy. Subst Use Misuse 2000
Oct-Dec;35(12-14):2095-125
Brooner RK, King VL, Kidorf M, Schmidt CW Jr, Bigelow GE. Psychiatric and
substance use comorbidity among treatment-seeking opioid abusers. Arch Gen
Psychiatry 1997 Jan;54(1):71-80
Buydens-Branchey L, Branchey M, Fergeson P, Hudson J, McKernin C. The
meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and
psychological responses. Biol Psychiatry 1997 Jun 1;41(11):1071-86
Carroll KM, Nich C, Rounsaville BJ. Differential symptom reduction in depressed
cocaine abusers treated with psychotherapy and pharmacotherapy. J Nerv Ment Dis
1995 Apr;183(4):251-9
Compton WM 3rd, Cottler LB, Ben Abdallah A, Phelps DL, Spitznagel EL, Horton JC.
Substance dependence and other psychiatric disorders among drug dependent
subjects: race and gender correlates. Am J Addict 2000 Spring;9(2):113-25
Craig, T. J., & DiBuono, M. (1996). Recognition of comorbid psychopathology
by staff of a drug detoxification unit. American Journal on Addictions, 5,
76-80.
Fischer G, Gombas W, Eder H, Jagsch R, Peternell A, Stuhlinger G, Pezawas L,
Aschauer HN, Kasper S. Buprenorphine versus methadone maintenance for the
treatment of opioid dependence. Addiction 1999 Sep;94(9):1337-47
Flynn PM, Luckey JW, Brown BS, Hoffman JA, Dunteman GH, Theisen AC, Hubbard RL,
Needle R, Schneider SJ, Koman JJ 3rd, et al. Relationship between drug
preference and indicators of psychiatric impairment. Am J Drug Alcohol Abuse
1995 May;21(2):153-66
Gastfriend DR, Lu SH, Sharon E. Placement matching: challenges and technical
progress. Subst Use Misuse 2000 Oct-Dec;35(12-14):2191-213
Gerra G. Drogati si nasce? Percorsi nell'infanzia-adolescenza prima della
tossicodipendenza . Ed. S. Paolo Torino , 1994.
Gerra G., Caccavari R., Delsignore R, Bocchi R., Fertonani G.,Passeri M. Effects
of fluoxetine and Ca-acetyl-homotaurinate on alcohol intake in familial and
nonfamilial alcoholic patients. Current Ther. Res. 1992, 52:291-295.
Gerra G., Caccavari R., Fontanesi B., Delsignore R., Fertonani AG., Marcato A.,
Maestri D, Avanzini P., Perna G., Brambilla F. Alpha-2-adrenoreceptors
sensitivity in heroin addicts with and without previous attention deficit
disorder/ hyperactivity and conduct disorder. Neuropsychobiology , 30: 15-19,
1994.
Gerra G., Calbiani B., Zaimovic A., Sartori R., Ugolotti G., Ippolito L.,
Delsignore R. Rustichelli P., Fontanesi B. Regional cerebral blood flow in
abstinent opioid addicts: correlation with personality traits. Psichiatry
Research 83:117-126, 1998.
Gerra G., Ferri M., Zaimovic A., Giucastro G., Palladino M., Sartori R.,
Delsignore R., Maestri D., Marzocchi G., Brambilla F. Gabaergic function in
detoxified heroin addicts: relationship to anxiety disorders. Psychiatry
Research, 77:89-96, 1998.
Gerra G., Fertonani G., Tagliavini P., Zaimovic A., Delsignore R., Maestri D.,
Avanzini P., Caccavari R. and Brambilla F. Serotonin function in detoxified
heroin abusers: prolactin and cortisol responses to fenfluramine challenge.
Psychiatry Research, 58: 153-160, 1995.
Gerra G., Fertonani G., Zaimovic A., Rota-Graziosi I., Avanzini P., Caccavari
R., Delsignore R. and Lucchini A. Hostility in heroin abusers subtypes:
fluoxetine and naltrexone treatment. Progress in Neuropsychopharmacology and
Biological Psychiatry, 19: 1225-1237,1995.
Gerra G., Zaimovic A., Timpano M., Zambelli U., Begarani M., Marzocchi G.F.,
Ferri M., Delsignore R., Brambilla F., Neuroendocrine correlates of temperament
traits in abstinent opiate addicts. J Subst Abuse 2000;11(4):337-54.
Gerra G., Zaimovic A., Zambelli U., Delsignore R., Baroni M.C., Laviola G.,
Macchia T., Brambilla F., Neuroendocrine correlates of depression in abstinent
heroin-dependent subjects. 96: 221-234, 2000.
Haney M, Gerra G, Fischman MW, Foltin RW Neuroendocrine effects of
d-fenfluramine after repated cocaine self-administration in humans. In press
Drug Alcohol Depend.
Helmus TC, Downey KK, Arfken CL, Henderson MJ, Schuster CR. Novelty seeking as a
predictor of treatment retention for heroin dependent cocaine users. Drug
Alcohol Depend 2001 Feb 1;61(3):287-95
Kadden, R. M., Kranzler, H. R., & Rounsaville, B. J. (1994). Validity of the
distinction between "substance-induced" and "independent"
depression and anxiety disorders. American Journal of Addictions, 4, 107-117.
Kaye S, Darke S, Finlay-Jones R. The onset of heroin use and criminal behaviour:
does order make a difference? Drug Alcohol Depend 1998 Dec 1;53(1):79-86
Kranzler HR. Pharmacotherapy of alcoholism: gaps in knowledge and opportunities
for research. Alcohol Alcohol 2000 Nov-Dec;35(6):537-47
Landabaso MA, Iraurgi I, Jimenez-Lerma JM, Sanz J, Fernadez de Corres B, Araluce
K, Calle R, Gutierrez-Fraile M. A randomized trial of adding fluoxetine to a
naltrexone treatment programme for heroin addicts. Addiction 1998
May;93(5):739-44
Levin FR, Evans SM, Coomaraswammy S, Collins ED, Regent N, Kleber HD.
Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study. Am
J Drug Alcohol Abuse 1998 Aug;24(3):343-60
Luthar SS, Rounsaville BJ. Substance misuse and comorbid psychopathology in a
high-risk group: a study of siblings of cocaine misusers. Int J Addict 1993
Apr;28(5):415-34
McDowell DM, Levin FR, Seracini AM, Nunes EV. Venlafaxine treatment of cocaine
abusers with depressive disorders. Am J Drug Alcohol Abuse 2000 Feb;26(1):25-31
Pani PP, Maremmani I, Pirastu R, Tagliamonte A, Gessa GL. Buprenorphine: a
controlled clinical trial in the treatment of opioid dependence. Drug Alcohol
Depend 2000 Jul 1;60(1):39-50
Pettinati HM, Volpicelli JR, Kranzler HR, Luck G, Rukstalis MR, Cnaan A.
Sertraline treatment for alcohol dependence: interactive effects of medication
and alcoholic subtype. Alcohol Clin Exp Res 2000 Jul;24(7):1041-9
Saxon AJ, Calsyn DA. Effects of psychiatric care for dual diagnosis patients
treated in a drug dependence clinic. Am J Drug Alcohol Abuse 1995
Aug;21(3):303-13
Schubiner H, Tzelepis A, Isaacson JH, Warbasse LH 3rd, Zacharek M, Musial J. The
dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse:
case reports and literature review. J Clin Psychiatry 1995 Apr;56(4):146-50
Shalev U, Yap J Shaham Y. Leptin attenuates acute food deprivation induced
relapse to heroin seeking. The Journal of Neuroscience, 2001, 21: 1-6.
Stewart J Pathways to relapse: the neurobiology of drug and stress induced
relapse to drug-taking. J Psychiatry Neurosci 2000; 25(1): 125-136.
|
|
| Primo Piano Dipartimento Politiche Antidroga
Presidenza del Consiglio dei Ministri |
- Principi generali della posizione italiana contro l’uso di droghe ( IT, EN)
- Accordo di collaborazione scientifica Italia-USA ( IT, EN)
- Dichiarazione DPA collaborazioni scientifiche internazionali ( IT, EN) |
|
|
|
| Oggi i giornali parlano di droga |
|
|
|
